- Scheme Category:
- Equity Scheme >
NAV: ₹ ↓ -0.31%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 40 SMA
- 500 SMA
Returns
CAGR returns till date
CAGR returns of PGIM India Healthcare Fund - Direct Plan - Growth Option and its peers as on 13 November, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| PGIM India Healthcare Fund - Direct Plan - Growth Option | 28.9% | -0.31% | 3.12% | 8.05% | 2.96% | 26.25% | - | - | - | - |
| HDFC Defence Fund - Growth Option - Direct Plan | 26.72% | -0.53% | 2.48% | -0.57% | -4.12% | 20.34% | 33.64% | - | - | - |
| HDFC Technology Fund - Growth Option - Direct Plan | -10.51% | -0.09% | -1.39% | 4.96% | 1.27% | -9.23% | 9.27% | - | - | - |
| Nippon India Consumption Fund - Direct Plan Growth Plan - Growth Option | -1.74% | -0.59% | 0.61% | 6.52% | -3.01% | -2.91% | 10.47% | 11.71% | 17.43% | 13.89% |
| Nippon India Japan Equity Fund- Direct Plan- Growth Plan- Growth Option | 18.3% | 0.5% | 4.17% | -6.09% | -7.84% | 18.3% | 20.52% | 9.4% | 10.55% | 10.86% |
| Nippon India US Equity Opportunities Fund- Direct Plan- Growth Plan- Growth Option | 10.4% | -0.56% | 1.6% | -3.42% | -2.22% | 12.92% | 18.42% | 10.66% | 15.28% | 16.32% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | - | -1.67% |
Discrete returns (monthly)
| Month | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -5.3% | 7.35% | -4.39% | 6.75% | 3.93% | 7.1% | 6.22% | 3.66% | -2.7% | -1.14% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 94.58% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 5.42% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 10.85% | |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.74% | |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 8.86% | |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.96% | |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 4.83% | |
| Manipal Health Enterprises Ltd. | (INE459N01021) | Healthcare Services | 4.12% | |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 4.07% | |
| Rubicon Research Ltd. | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 4.01% | |
| Dr. Lal Path Labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 3.93% | |
| Neuland Laboratories Ltd. | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.26% | |
| Krishna Inst of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 3.15% | |
| Navin Fluorine International Ltd. | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 3.04% | |
| Aster DM Quality Care Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 2.89% | |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.83% | |
| Sai Life Sciences Ltd | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.54% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 2.23% | |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 2.12% | |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.96% | |
| Jupiter Life Line Hospitals Ltd. | (INE682M01020) | Healthcare Services | 1.77% | |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 1.72% | |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.51% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 1.42% | |
| ICICI Lombard General Insurance Co. Ltd. | ICICIGI (INE765G01017) | Insurance | 1.40% | |
| Dr Agarwal's Eye Hospital Ltd. | DRAGARWQ (INE934C01018) | Healthcare Services | 1.20% | |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 1.10% | |
| Dr Agarwal's Health Care Ltd. | AGARWALEYE (INE943P01029) | Healthcare Services | 0.86% | |
| Orchid Pharma Ltd. | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.80% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 0.73% | |
| Lenskart Solutions Ltd. | LENSKART (INE956O01016) | Retailing | 0.71% | |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 0.51% | |
| Sagility Ltd. | SAGILITY (INE0W2G01015) | IT - Services | 0.46% |
Portfolio data is as on date 31 August, 2026
NAV history
PGIM India Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 13 November, 2026 | 12.89 | -0.31% |
| 12 November, 2026 | 12.93 | 0.47% |
| 11 November, 2026 | 12.87 | 0% |
| 9 November, 2026 | 12.87 | 2.96% |
| 6 November, 2026 | 12.5 | 0.73% |
| 5 November, 2026 | 12.41 | 0.49% |
| 4 November, 2026 | 12.35 | 1.4% |
| 3 November, 2026 | 12.18 | 0.66% |
| 2 November, 2026 | 12.1 | 0% |
| 30 October, 2026 | 12.1 | 1% |
| 29 October, 2026 | 11.98 | 0.08% |
| 28 October, 2026 | 11.97 | 0.76% |
| 27 October, 2026 | 11.88 | 2.15% |
| 26 October, 2026 | 11.63 | 1.39% |
| 23 October, 2026 | 11.47 | -1.04% |
| 22 October, 2026 | 11.59 | -0.09% |
| 21 October, 2026 | 11.6 | -0.34% |
| 19 October, 2026 | 11.64 | -0.94% |
| 16 October, 2026 | 11.75 | -0.42% |
| 15 October, 2026 | 11.8 | -0.25% |
| 14 October, 2026 | 11.83 | -0.84% |
| 13 October, 2026 | 11.93 | -0.58% |
| 12 October, 2026 | 12 | -0.08% |
| 9 October, 2026 | 12.01 | 0.5% |
| 8 October, 2026 | 11.95 | -2.05% |
| 7 October, 2026 | 12.2 | -0.25% |
| 6 October, 2026 | 12.23 | 0.99% |
| 5 October, 2026 | 12.11 | -1.06% |
| 1 October, 2026 | 12.24 | -0.08% |
| 30 September, 2026 | 12.25 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of PGIM India Healthcare Fund - Direct Plan - Growth Option is 12.89 as on 13 November, 2026.What are YTD (year to date) returns of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of PGIM India Healthcare Fund - Direct Plan - Growth Option are 28.9% as on 13 November, 2026.What are 1 year returns of PGIM India Healthcare Fund - Direct Plan - Growth Option?
The 1 year returns of PGIM India Healthcare Fund - Direct Plan - Growth Option are 26.25% as on 13 November, 2026.What are top 10 holdings of PGIM India Healthcare Fund - Direct Plan - Growth Option?
Top 10 holdings of PGIM India Healthcare Fund - Direct Plan - Growth Option are:- Divi's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Max Healthcare Institute Ltd.
- Ajanta Pharma Ltd.
- Manipal Health Enterprises Ltd.
- Mankind Pharma Ltd.
- Rubicon Research Ltd.
- Dr. Lal Path Labs Ltd.
- Neuland Laboratories Ltd.
- Krishna Inst of Medical Sciences Ltd.
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for PGIM India Healthcare Fund - Direct Plan - Growth Option?
PGIM India Healthcare Fund - Direct Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.